logo

For the Inventor, By the Inventor

Menlo Park, CA, United States of America

Intersect Ent Gmbh


USPTO Granted Patents = 48



Trademarks = 17

Forward Citations = 2,651

Loading Chart...
Loading Chart...

28 inventors (with patents filed for the assignee):

goldMedal Donald J Eaton (25 out of 37 patents)

silverMedal Anthony J Abbate (20 out of 42 patents)

bronzeMedal Rodney A Brenneman (18 out of 124 patents)

4.  Bin Huang (13 out of 119 patents)

5.  Gail M Zaler (13 out of 13 patents)

6.  David C Gale (13 out of 149 patents)

7.  Richard E Kaufman (10 out of 11 patents)

8.  Mary Lynn Moran (10 out of 14 patents)

9.  Patrick A Arensdorf (8 out of 19 patents)

10.  Thomas R Tice (8 out of 49 patents)

11.  David B Downie (8 out of 8 patents)

12.  Danielle L Biggs (7 out of 18 patents)

13.  John Joseph Stankus (7 out of 73 patents)

14.  James Su (6 out of 15 patents)

15.  Vijaykumar Reddy Rajasekhar (3 out of 17 patents)


Core Competencies:
Bioresorbable Drug Delivery
Drug-Coated Balloon
Self-Expanding Devices
Expandable Member Systems
Sinus Treatment Devices
Medical Navigation Systems
Sustained Release Therapeutics
Paranasal Sinus Treatments
Active Agent Delivery
Tissue Dilation Devices
Symmetrical Body Reconstruction
Irrigation Stents

48 patents:

1. 12551672 - Systems, devices, and method for treating a sinus condition (2026-02-17),
2. 12403291 - Submucosal bioresorbable drug eluting platform (2025-09-02),
3. 12064577 - Drug-coated balloon (2024-08-20),
4. 11826494 - Self-expanding devices and methods therefor (2023-11-28),
5. 11672960 - Systems, devices, and method for treating a sinus condition (2023-06-13),
6. 11672959 - Expandable member systems and methods for drug delivery (2023-06-13),
7. 11654216 - Self-expanding devices and methods therefor (2023-05-23),
8. 11497835 - Self-expanding devices and methods therefor (2022-11-15),
9. 11484693 - Expandable devices and methods for treating a nasal or sinus condition (2022-11-01),
10. 11413096 - System for the reconstruction of symmetrical body parts (2022-08-16),
11. 11337661 - Medical navigation system with wirelessly connected, touch-sensitive screen (2022-05-24),
12. 11291812 - Sinus delivery of sustained release therapeutics (2022-04-05),
13. 11123091 - Device and methods for treating paranasal sinus conditions (2021-09-21),
14. 11110210 - Self-expanding devices and methods therefor (2021-09-07),
15. 10814108 - Drug-coated balloon (2020-10-27),
Intersect ENT GmbH is a biotechnology company focused on providing innovative solutions for patients with ear, nose, and throat (ENT) conditions. With a mission to improve the quality of life for patients suffering from chronic sinusitis, Intersect ENT GmbH develops and commercializes advanced products that enable minimally invasive treatments. Their flagship product, PROPEL sinus stent, helps maintain sinus openings and improve post-surgical outcomes. Intersect ENT GmbH is committed to advancing the treatment options available to ENT specialists and providing relief to patients.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Intersect Ent Gmbh
48 Patents

#32 in Menlo Park, CA

#1,711 in California

#7,275 in US

#14,527 in the World

Menlo Park, CA (US)
Menlo Park, CA, United States of America

Intersect Ent Gmbh

Forward Citations = 2,651

28 inventors:

goldMedal Donald J Eaton (25 out of 37 patents)

silverMedal Anthony J Abbate (20 out of 42 patents)

bronzeMedal Rodney A Brenneman (18 out of 124 patents)

4.  Bin Huang (13 out of 119 patents)

5.  Gail M Zaler (13 out of 13 patents)

Please report any incorrect information to [email protected]
Loading…